Group | Prostate cancer (N = 75) Mean ± SD (range) | Prostatic hyperplasia (N = 60) Mean ± SD (range) | Apparently healthy (N = 45) Mean ± SD (range) |
Factors | |||
PSA ng/ml | 67.52 ± 123.66 (4.62 - 1030) | 15.41 ± 20.68 (2.45 - 92.78) | 1.93 ± 1.04 (0.33 - 3.80) |
fPSA ng/ml | 8.04 ± 15.04 (0.48 - 122) | 4.15 ± 6.77 (0.44 - 35.12) | 0.48 ± 0.29 (0.10 - 1.22) |
KLK-2 ng/ml | 0.41 ± 0.54 (0.03 - 2.33) | 0.22 ± 0.24 (0.02 - 0.74) | 0.15 ± 0.13 (0.02 - 0.51) |
fPSA/PSA (%) | 12.57 ± 7.31 (5.91 - 67.13) | 23.66 ± 7.50 (8.39 - 45.36) | 25.83 ± 7.75 (13.61 - 43.08) |
KLK-2/PSA (%) | 0.661 ± 0.49 (0.05 - 1.94) | 1.52 ± 1.01 (0.39 - 4.62) | 7.61 ± 4.13 (2.91 - 22.12) |
KLK-2/fPSA (%) | 6.03 ± 4.17 (0.272 - 19.95) | 7.47 ± 6.70 (1.50 - 39.57) | 30.33 ± 13.8 (8.15 - 58.38) |